Patients with prostate cancer should be enrolled in a national, controlled trial

BMJ 1999; 318 doi: 10.1136/bmj.318.7176.126 (Published 9 January 1999)
Cite this as: BMJ 1999;318:126.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. R G Willis, Consultant urologist
  1. Carlisle Hospitals NHS Trust, Cumberland Infirmary, Carlisle CA2 7HY

    EDITOR—I endorse the views of Mulley and Barry on treating prostate cancer.1 British urologists are deluged with data from the United States which encourages radical prostatectomy, yet there is no good evidence from randomised controlled trials to validate their policy.

    If the editorial had been written by an American urologist the conclusion would have been entirely different. Mulley and Barry failed to emphasise the powerful financial motives behind much of what is published about prostate cancer in the …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL